Macrogol En Elektrolyten (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that is not absorbed from the gut. It retains water in the intestinal lumen through osmotic pressure, softening the stool and increasing its volume. The added electrolytes help maintain normal electrolyte balance while the increased fluid promotes peristalsis.

The dose of Macrogol En Elektrolyten is individualized by the prescribing healthcare professional based on the patient’s age, weight, severity of constipation and clinical situation. The prescriber determines the appropriate amount and frequency, and patients should follow the specific instructions provided on the prescription label.

Safety data for Macrogol En Elektrolyten in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate the individual situation and advise whether the product is appropriate during pregnancy or while breastfeeding.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the enquiry, the sales team will request trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Compared with stimulant laxatives, macrogol‑based products act osmotically and are generally better tolerated, causing fewer cramping and electrolyte disturbances. Unlike simple saline laxatives, the inclusion of electrolytes in Macrogol En Elektrolyten helps maintain fluid balance, making it suitable for longer‑term use under medical supervision.

Store Macrogol En Elektrolyten at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight and extreme temperatures to preserve product stability and potency.

The product is supplied as an oral powder that is dissolved in water or another clear fluid according to the prescribing information. The solution is then consumed as directed by the healthcare professional, typically once daily or as needed for bowel cleansing.

Serious risks include electrolyte imbalance (such as hypernatremia or hypokalemia), severe dehydration, allergic reactions, and rare cases of intestinal obstruction or perforation, especially in patients with pre‑existing gastrointestinal pathology. Prompt medical attention is required if severe abdominal pain, persistent diarrhea, or signs of an allergic reaction occur.

Macrogol En Elektrolyten should be avoided in individuals with known or suspected mechanical bowel obstruction, severe renal impairment, uncontrolled electrolyte disorders, or hypersensitivity to any of its components. Pediatric use should be under strict medical supervision, and patients with a history of severe gastrointestinal disease should be evaluated before use.